Page last updated: 2024-11-06

floxuridine and Carcinoma, Transitional Cell

floxuridine has been researched along with Carcinoma, Transitional Cell in 3 studies

Floxuridine: An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
floxuridine : A pyrimidine 2'-deoxyribonucleoside compound having 5-fluorouracil as the nucleobase; used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.

Carcinoma, Transitional Cell: A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS.

Research Excerpts

ExcerptRelevanceReference
"A total of 112 patients with pTa or pT1 bladder cancer were eligible for the analysis and were allocated to either an adjuvant group (TURBT+5'-DFUR; n = 47; initial 23 months) or a control group (TURBT alone; n = 65, final 23 months)."6.71Novel prophylactic effect of doxifluridine in superficial bladder cancer. ( Aoki, A; Baba, Y; Jojima, K; Matsuyama, H; Naito, K; Shimabukuro, T; Suga, A; Suyama, K; Uchiyama, K; Yamamoto, N, 2004)
"A total of 112 patients with pTa or pT1 bladder cancer were eligible for the analysis and were allocated to either an adjuvant group (TURBT+5'-DFUR; n = 47; initial 23 months) or a control group (TURBT alone; n = 65, final 23 months)."2.71Novel prophylactic effect of doxifluridine in superficial bladder cancer. ( Aoki, A; Baba, Y; Jojima, K; Matsuyama, H; Naito, K; Shimabukuro, T; Suga, A; Suyama, K; Uchiyama, K; Yamamoto, N, 2004)
"Human solid tumor histocultures represent a clinically relevant experimental system for pharmacodynamic study."1.30Regional heterogeneity and pharmacodynamics in human solid tumor histoculture. ( Au, JL; Weaver, JR; Wientjes, MG, 1999)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Matsuyama, H1
Baba, Y1
Shimabukuro, T1
Uchiyama, K1
Aoki, A1
Suga, A1
Jojima, K1
Suyama, K1
Yamamoto, N1
Naito, K1
Weaver, JR1
Wientjes, MG1
Au, JL1
Kubota, Y1
Miura, T1
Shuin, T1
Kinoshita, Y1
Hosaka, M1
Kondo, I1
Moriyama, M1
Fukushima, S1
Fukuoka, H1
Miyai, K1

Trials

1 trial available for floxuridine and Carcinoma, Transitional Cell

ArticleYear
Novel prophylactic effect of doxifluridine in superficial bladder cancer.
    Scandinavian journal of urology and nephrology, 2004, Volume: 38, Issue:5

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Carcinoma, Transitional Cell; Cystectomy; Dose

2004

Other Studies

2 other studies available for floxuridine and Carcinoma, Transitional Cell

ArticleYear
Regional heterogeneity and pharmacodynamics in human solid tumor histoculture.
    Cancer chemotherapy and pharmacology, 1999, Volume: 44, Issue:4

    Topics: Antineoplastic Agents; Carcinoma, Transitional Cell; Cell Division; Culture Techniques; Drug Screeni

1999
[Phase II study of 5'-DFUR (Furtulon) capsule for bladder cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1991, Volume: 18, Issue:13

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Anorexia; Antineoplastic Agents; Carcinoma, Squamous

1991